Literature DB >> 8932873

Age at diagnosis and multiple primary cancers of the breast and ovary.

P J Suris-Swartz1, J M Schildkraut, M F Vine, I Hertz-Picciotto.   

Abstract

This nested case-control study assessed the relationship between a woman's age at the time of her initial primary breast or ovarian cancer diagnosis and the risk of a second primary cancer at the other of these two sites. Multiple primary breast and ovarian cancer cases whose initial breast or ovarian diagnosis occurred in 1970-1989 and a random sample of single primary breast or ovarian cancer controls diagnosed in the same years were identified through tumor registries at Duke University Medical Center and the University of North Carolina. Women diagnosed with an initial primary breast cancer at age < or = 50 years were 4.3 times (95% CI: 1.8-10.6) more likely to have developed a subsequent ovarian cancer compared to those diagnosed after age 50. A relationship between an early age at diagnosis (< or = 50) of ovarian cancer and subsequent diagnosis of breast cancer was not found (odds ratio (OR) = 0.6; 95% CI: 0.2-2.0). Adjustment for stage at diagnosis, treatment, year of diagnosis and length of follow-up using Cox Proportional Hazards modeling techniques supported these relationships, yielding a hazard ratio (HR) for the development of a second primary cancer at the alternate site of 4.6 (95% CI: 1.8-11.5) for women with an initial breast cancer diagnosis and 0.6 (95% CI: 0.2-2.2) for women with an initial ovarian cancer diagnosis. Multiple primary breast and ovarian cancer patients diagnosed with an initial breast cancer at or prior to age 50 may represent a distinct subgroup of women with a germline mutation that confers susceptibility to both breast and ovarian cancers.

Entities:  

Mesh:

Year:  1996        PMID: 8932873     DOI: 10.1007/bf01807033

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  27 in total

1.  How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach.

Authors:  E J Feuer; L M Wun
Journal:  Am J Epidemiol       Date:  1992-12-15       Impact factor: 4.897

2.  Carcinoma of the breast and ovary in three families.

Authors:  H T Lynch; A J Krush
Journal:  Surg Gynecol Obstet       Date:  1971-10

3.  Inherited breast and ovarian cancer. What are the risks? What are the choices?

Authors:  M C King; S Rowell; S M Love
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

Review 4.  Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer.

Authors:  A M Bowcock
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

5.  Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry.

Authors:  S Shah; D G Evans; V Blair; L D Burnell; J M Birch
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

Review 6.  Epidemiology of breast cancer. Findings from the nurses' health study.

Authors:  G A Colditz
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

7.  Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship.

Authors:  J M Schildkraut; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

Review 8.  Age contrast in ovarian pathology.

Authors:  M J Merino; G Jaffe
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

9.  A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.

Authors:  B S Kramer; J Gohagan; P C Prorok; C Smart
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

10.  Multiple primary cancers of the breast and ovary.

Authors:  P Prior; J A Waterhouse
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

View more
  1 in total

1.  The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients.

Authors:  Qingli Zhang; Qinghui Zhang; Hua Cong; Xiaoli Zhang
Journal:  Diagn Pathol       Date:  2012-12-31       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.